Yamila Carpio González (Havana, 1975) is a Cuban scientist recognized for her contributions to molecular biology and veterinary immunology. She earned her Bachelor’s degree in Biology (1998), followed by a Master’s in Biochemistry and Molecular Biology (2004) and a PhD in Molecular Biology (2010) from the University of Havana, where she focused on the role of myostatin inhibitors in fish growth. After a postdoctoral fellowship in aquatic biotechnology, she joined the Center for Genetic Engineering and Biotechnology (CIGB), where she currently leads the Veterinary Immunology Project. Her expertise spans gene cloning, recombinant protein expression, vaccine development, and immunological assays. Carpio has authored more than 80 peer-reviewed publications in high-impact journals and holds several patents related to aquaculture and vaccine innovation. She has spearheaded projects on vaccines against sea lice, SARS-CoV-2, and Brucella spp., securing international collaborations and funding. Her work has been recognized with prestigious awards, including the C.J. Finlay Medal, the Juan Tomás Roig Medal, and multiple Cuban Academy of Sciences honors. Her career reflects a commitment to advancing sustainable biotechnological solutions for animal health, positioning her as a leading figure in comparative immunology and marine biotechnology.